Lactel 75:25 DL-PLG (B6012-1) Biomedical Acid-Terminated PLGA is an absorbable copolymer of DL-lactide and glycolide in a 75:25 molar ratio, with free terminal carboxylic acid groups rather than ester-capped chain ends. The B6012-1 product code distinguishes the acid-terminated member of the 75:25 DL-PLG series from ester-capped analogues of equivalent comonomer ratio. The polymer is amorphous because the racemic DL-lactide repeat unit suppresses stereoregular crystallization, and it is supplied as a solid resin intended for dissolution in chlorinated or polar aprotic solvents for drug encapsulation, microsphere fabrication, implant coating, electrospinning, or absorbable device component manufacture. The raw material is not a finished medical product; chemical characterization, residual impurity control, and biological evaluation are therefore managed under ISO 10993-18:2020 and pharmacopeial methods appropriate to the intended use.

Product selection typically begins with the acid-end-group chemistry rather than the comonomer ratio alone. Ester-capped 75:25 DL-PLG carries alkyl ester chain termini, whereas B6012-1 presents ionizable carboxylic acid groups. The difference alters early water uptake, interfacial pH, and ionic interaction with peptide or protein cargo during encapsulation. DL-lactide rather than L-lactide prevents the crystalline domains observed in poly(L-lactide) homopolymer and provides a lower glass transition temperature and faster hydrolytic degradation than semicrystalline poly(L-lactide). Relative to 50:50 DL-PLG at equivalent molecular weight, the 75:25 ratio reduces glycolide repeat-unit density and slows hydrolytic chain scission; relative to 85:15 DL-PLG, the 75:25 ratio shortens the expected resorption window under identical device geometry and porosity.

What Distinguishes Acid-Terminated 75:25 DL-PLG from Ester-Capped and Lower-Ratio Grades?

The free acid terminus is not a passive structural detail. In aqueous environments, carboxylic acid end groups raise local chain hydrophilicity and can lower interfacial pH, which accelerates ester-bond hydrolysis during the early degradation phase before autocatalytic bulk erosion dominates. The ester-capped equivalent lacks this initial ionizable end-group population and hydrates more slowly under identical geometry, molecular weight, and temperature. Published in vitro hydrolysis studies in phosphate-buffered saline at 37 °C and pH 7.4 show that degradation rate is not determined solely by end-group chemistry; molecular weight, specimen thickness, porosity, buffer exchange, and local accumulation of lactic and glycolic acid can dominate the observed mass-loss profile.

The acid end group also creates a handling boundary that is less prominent in ester-capped grades. The terminal carboxylic acid can form ionic complexes with amine-containing peptides and proteins, which may increase encapsulation efficiency but also change release kinetics and reduce the free fraction of basic drug during early release. Formulations containing acid-labile active ingredients or amine-functional excipients should therefore be evaluated for ionic precipitation, salt formation, or pH-driven degradation before committing to a solvent-evaporation or spray-drying process. The 75:25 ratio is selected when slower degradation than 50:50 DL-PLG is required but 85:15 DL-PLG would persist beyond the target resorption window; however, terminal acid groups on B6012-1 can narrow that window relative to ester-capped 75:25 DL-PLG under identical processing history.

In aqueous environments at 37 °C and pH 7.4, water uptake by the amorphous 75:25 DL-PLG matrix precedes ester-bond cleavage. The glass transition temperature reported in the literature for 75:25 PLGA is commonly in the range of 45–50 °C, depending on molecular weight and residual solvent; absorbed water plasticizes the matrix and lowers the effective Tg below the incubation temperature, increasing chain mobility and hydrolysis rate. Hydrolytic degradation produces lactic acid and glycolic acid. In thick implants or large microspheres, acidic byproducts cannot diffuse out rapidly, producing internal autocatalysis and faster core degradation than surface erosion. B6012-1 adds an additional carboxylic acid source at the chain termini, which can contribute to this autocatalytic process during early hydration. The resulting heterogeneous degradation is a critical processing consideration for microsphere release testing and implant mechanical integrity.

Specification Framework and Certificate-of-Analysis Parameters

The B6012-1 standard grade is commonly specified with an inherent viscosity range of 0.55–0.75 dL/g when measured in chloroform at 25 °C and 0.1 g/dL, with the exact value reported on each lot certificate of analysis. Size-exclusion chromatography with refractive index or multi-angle light scattering in hexafluoroisopropanol or tetrahydrofuran is used to characterize number-average molecular weight, weight-average molecular weight, and dispersity. Acid termination can be confirmed by titration of carboxylic acid content or by end-group analysis using ¹H NMR. Residual lactide and glycolide monomers are controlled because unreacted monomer can migrate and contribute to local irritation or plasticization. Residual process solvents such as dichloromethane or ethyl acetate are measured by headspace gas chromatography under USP <467> protocols. Tin residues from stannous octoate catalyst are quantified by inductively coupled plasma mass spectrometry because tin is used in the ring-opening polymerization of lactide and glycolide.

The material should be stored in moisture-barrier packaging under refrigeration or frozen conditions typical for absorbable polyesters, and the package should be equilibrated to ambient temperature before opening to avoid condensation. A maximum moisture content of 0.5 wt% by Karl Fischer titration is frequently used as the pre-drying target before melt processing, because residual moisture accelerates hydrolytic chain scission at elevated temperature. Biocompatibility screening of the raw polymer may be carried out using ISO 10993-5:2009 cytotoxicity testing, but finished-device biological evaluation under ISO 10993-1:2018 is still required because processing aids, sterilization, and degradation products can alter the final biological response.

For emulsion-based encapsulation of water-soluble peptides or proteins, B6012-1 is dissolved in an organic phase such as dichloromethane or ethyl acetate at concentrations commonly between 1% and 20% w/v, depending on target microsphere size and solution rheology. The aqueous drug solution or suspension is dispersed into the organic phase by rotor-stator homogenization to form a water-in-oil emulsion; this primary emulsion is then transferred into an external aqueous poly(vinyl alcohol) phase to form a water-in-oil-water emulsion. Droplet size is measured by laser diffraction per ISO 13320. Particle size is controlled primarily by impeller tip speed, continuous-phase viscosity, and external-phase stabilizer concentration; tip speed rather than impeller speed is the usual scale-up variable in rotor-stator emulsification. After solvent extraction or evaporation, the microspheres are washed, filtered, and lyophilized. Residual moisture after lyophilization is measured by Karl Fischer titration per ISO 15512 or an equivalent pharmacopeial method. For organic-soluble actives, a single oil-in-water emulsion may be used. The polymer solution should be filtered through a 0.2 µm membrane to reduce bioburden before aseptic processing.

When Terminal Carboxylic Acid Content Accelerates Early Hydrolysis in Aqueous Formulations

The acid terminus exerts the strongest processing and stability influence during early aqueous exposure. In dilute solution or high-surface-area microspheres, free carboxylic acid end groups can increase water uptake and catalyze ester hydrolysis, so molecular weight may decline faster during the first 24–72 h than an ester-capped analogue of equivalent comonomer ratio and molecular weight. This is relevant to formulations that are terminally sterilized by gamma irradiation or exposed to moisture during lyophilization or delayed packaging. Irradiation can induce chain scission and free-radical reactions that increase carboxylic acid content and reduce melt viscosity. Published irradiation data for this specific B6012-1 configuration is limited; dose mapping and post-irradiation inherent-viscosity or size-exclusion chromatography testing are therefore required. If gamma sterilization is selected, dose establishment follows ISO 11137-1:2006 and ISO 11137-2:2013, and the molecular-weight shift must be characterized for each lot and irradiation configuration.

The acid end groups can interact with amine-containing cationic peptides through ionic complexation. This may improve encapsulation efficiency by retaining peptide in the polymer phase, but it can also delay release or alter the local pH within the degrading microsphere. In PLGA microspheres, the internal pH microenvironment can become acidic during bulk erosion, and acid-labile proteins may lose activity if not protected by buffering excipients. B6012-1 should be considered in that context because the terminal carboxyl groups are part of the same acidic microenvironment. Formulations containing amine-functional additives should be evaluated for premature ionic association with the polymer chain ends, which can alter emulsion stability and drug distribution.

In melt extrusion of B6012-1 on a twin-screw extruder with L/D ratio from 25:1 to 40:1, pre-drying to a low moisture specification is required before processing. A vacuum oven or desiccant-dry-air dryer is used because moisture-driven hydrolysis at barrel temperature can reduce intrinsic viscosity during compounding. Extruder barrel temperatures are frequently profiled downward from the feed throat to the die to limit thermal history, and processing above 120 °C can produce measurable intrinsic-viscosity loss in the presence of residual moisture or prolonged residence time. A vented extruder under vacuum removes volatile residual solvents and moisture. Because B6012-1 is amorphous, strand cooling and pellet cutting may require lower die temperatures and faster cooling than semicrystalline biodegradable polymers to prevent sticking or strand breakage. Steam autoclaving is generally incompatible with this polymer because hydrolytic degradation accelerates under saturated moisture and high temperature; terminal sterilization by gamma irradiation may be used only after validation of molecular-weight retention and degradation product formation at the selected dose.